Apellis Pharmaceuticals, Inc. (APLS): 8-K filed May 14, 2026

Form type

8-K

Filing date

May 14, 2026

Accession number

0001193125-26-222923

Filer

Apellis Pharmaceuticals, Inc. (CIK 1492422)